The Use of Antiviral Drugs in the Prevention and Treatment of Kaposi Sarcoma, Multicentric Castleman Disease and Primary Effusion Lymphoma
- 31 December 2006
- book chapter
- Published by Springer Nature
- Vol. 312, 289-307
Abstract
Kaposi sarcoma-associated herpesvirus [KSHV, also known as human herpesvirus 8 (HHV-8)] is the most recently identified member of the human herpesvirus family. Kaposi sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease are all associated with KSHV infection. Although the incidence of KS has declined dramatically in areas with access to highly active antiretroviral therapy, it remains the most common AIDS-associated malignancy in the developed world and is one of the most common cancers in developing nations. Current treatment options for KSHV-associated disease are ineffective, unavailable, or toxic to many affected persons. A growing body of basic science, preclinical, and observational data suggests that antiviral medications may play an important role in the prevention and treatment of KSHV-associated disease.Keywords
This publication has 65 references indexed in Scilit:
- Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral TherapyJNCI: Journal of the National Cancer Institute, 2005
- Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiationVirology, 2004
- Failure of cidofovir in HIV-associated multicentric Castleman diseaseBlood, 2004
- Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatmentBlood, 2004
- Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimenAIDS, 2003
- Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virusAIDS, 2003
- Detection of DNA of Lymphotropic Herpesviruses in Plasma of Human Immunodeficiency Virus-Infected Patients: Frequency and Clinical SignificanceClinical and Vaccine Immunology, 2002
- Human Herpesvirus 8–Positive Castleman Disease in Human Immunodeficiency Virus–Infected Patients: The Impact of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- Quantification of human herpesvirus 8 by real‐time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's diseaseJournal of Medical Virology, 2002
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994